The Latest Breaking News from Obesity

Novo Nordisk stock slumped Thursday after its weight loss blockbuster, Wegovy, missed sales expectations despite rocketing demand.

Ex-chancellor urges UK PM extend sugar tax and raise legal age for tobacco to curb obesity and cancer

Department of Health asks watchdog to assess effectiveness of giving semaglutide to obese youngsters aged 12 to 17

This blog is now closed

According to a study to be presented at Digestive Disease Week (DDW) 2023, just 4% of patients with obesity who underwent bariatric surgery developed obesity-associated cancer in a 10-year follow-up, compared to 8.9% of those who did not have a weight-loss treatment. Read further on Dynamite News:

This trade is a neutral to bullish position and anticipates the stock holding above 390 over the summer term.

A weekly injection of tirzepatide has seen people with obesity and diabetes lose over 15 percent of their bodyweight.

Since the drug was first approved last year, thousands of patients have obtained the drug from doctors and telehealth providers who prescribed it "off-label" to help them slim down

Uterine cancer is generally more common in older women and is long known to disproportionately strike Black women. Now, new research adds to growing evidence that uterine cancer also is rising rapidly among reproductive-aged Hispanic women.